Agilent Technologies, Inc.

NYSE:A Voorraadrapport

Marktkapitalisatie: US$36.5b

Agilent Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Agilent Technologies heeft een totaal eigen vermogen van $5.9B en een totale schuld van $2.9B, wat de schuld-eigenvermogensverhouding op 49.7% brengt. De totale activa en totale passiva bedragen respectievelijk $11.0B en $5.1B. De EBIT Agilent Technologies is $1.3B waardoor de rentedekking 101.1 is. Het heeft contanten en kortetermijnbeleggingen van $1.8B.

Belangrijke informatie

49.7%

Verhouding schuld/eigen vermogen

US$2.93b

Schuld

Rente dekkingsratio101.1x
ContantUS$1.78b
AandelenUS$5.90b
Totaal verplichtingenUS$5.09b
Totaal activaUS$11.00b

Recente financiële gezondheidsupdates

Recent updates

Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

Oct 21
Here's Why Agilent Technologies (NYSE:A) Can Manage Its Debt Responsibly

With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Sep 23
With EPS Growth And More, Agilent Technologies (NYSE:A) Makes An Interesting Case

Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Sep 09
Agilent Technologies' (NYSE:A) Profits May Not Reveal Underlying Issues

Agilent: A 'Buy' Due To Growing Biopharma, PFAS, And Semi

Aug 23

A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Aug 14
A Look At The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent: Making A Move To Ignite Some Growth

Jul 25

Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Jul 15
Agilent Technologies (NYSE:A) Has A Pretty Healthy Balance Sheet

Is Agilent A Buy Before Earnings? Examining The Pros And Cons

May 23

Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

May 22
Should You Investigate Agilent Technologies, Inc. (NYSE:A) At US$154?

Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

May 07
Subdued Growth No Barrier To Agilent Technologies, Inc.'s (NYSE:A) Price

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Apr 05
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well

Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold

Mar 12

Agilent Technologies Hit A Homerun

Dec 24

Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)

Dec 08

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Dec 07
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Agilent Technologies: Looking Undervalued Heading Into Earnings

Nov 17

Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Oct 26
Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart

Sep 26

Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Sep 08
Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?

Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Aug 21
Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Jul 23
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)

Agilent Technologies - A Wealth Compounder 30% Below Its Highs

Jul 13

Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

Jul 10
Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today

What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

May 28
What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?

Agilent Technologies Stock: Starting To Look Appealing

May 25

These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely

Apr 17
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $4.3B ) A } overtreffen de korte termijn passiva ( $2.4B ).

Langlopende schulden: De kortetermijnactiva A ( $4.3B ) overtreffen de langetermijnschulden ( $2.7B ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 19.5% ) A wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van A is de afgelopen 5 jaar gestegen van 37.9% naar 49.7%.

Schuldendekking: De schuld van A wordt goed gedekt door de operationele kasstroom ( 60.9% ).

Rentedekking: De rentebetalingen op de schuld van A worden goed gedekt door EBIT ( 101.1 x dekking).


Balans


Ontdek gezonde bedrijven